Dr. Reddy’s Laboratories Ltd. is launching of Doxycycline Capsules, 40mg in the U.S. market, a therapeutic generic equivalent of Oracea (Galderma) Capsules, 40 mg approved by the U.S. Food and Drug Administration (USFDA). Oracea is indicated for the treatment of only inflammatory lesions of rosacea in adult patients.
Dr. Reddy’s Doxycycline Capsules, 40 mg, are supplied in bottle counts of 30.
